Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: CERUS CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2021-10-01 to 2025-09-30
Current total value of award: $258240
Description: INTERCEPT PLATELET PATHOGEN REDUCTION SET (TAMC), DEOBLIGATION OF FY22 FUNDS FROM BASE PERIOD.